vidarabine has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arampatzis, S; Eleftheriadis, T; Giannakoulas, N; Karasavvidou, F; Kourti, P; Liakopoulos, V; Matsouka, P; Stefanidis, I | 1 |
1 other study(ies) available for vidarabine and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Myeloablative Agonists; Rituximab; Vidarabine | 2011 |